US Patent 7608592 HCV inhibitors

Patent 7608592 was granted and assigned to Virobay on October, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Virobay

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7608592

Date of Patent

October 27, 2009

Patent Application Number

11478337

Date Filed

June 28, 2006

Patent Primary Examiner

‌

Jeffrey E. Russel

Patent abstract

The present invention is directed to compounds that are antiviral agents. Specifically the compounds of the present invention inhibit replication of HCV and are therefore useful in treating hepatitis C infections. The present invention is also directed to pharmaceutical compositions comprising these compounds and processes for preparing them.